This content is machine translated Metastatic non-small cell lung cancer Drug therapy 2014 Determination of EGFR mutational status and EML-ALK translocations in patients with metastatic adenocarcinoma has therapeutic implications and should be requested at diagnosis. Maintenance treatment with pemetrexed in patients with non-squamous…
View Post 12 min This content is machine translated Non-small cell lung cancer Individualized, palliative first-line therapy is possible Therapy for non-small cell lung cancer is individualized and based on tumor stage, histology, and predictive molecular markers, taking into account the patient profile. To maximize the therapeutic outcome for…
